Age related Macular degeneration (AMD) affects more than 100 million people world-wide. There are over 11 million sufferers of this disease in the U.S. alone and the prevalence is forecast to increase to 20 million by 2020 due to the greying of the baby-boomers.
The degeneration of the macula, the most sensitive portion of the retina, results in the loss of central vision. This is normally the area of best visual acuity. The remaining vision of an AMD sufferer is limited to the lower-acuity peripheral vision.
Traditionally, low vision specialists fit small telescopes to eye glasses to enable a patient to see some level of detail for distance viewing. These bioptic telescopes provide very narrow fields of view and are cosmetically unacceptable to many AMD patients. High powered microscopic lenses are prescribed for reading. An AMD sufferer must hold reading material at very close distances with these microscopic glasses and the reading material must be properly illuminated. Low vision specialists also prescribe illuminated magnifiers or closed circuit television (CCTV) systems to help the AMD patient read normal print. In each case, the aids are either cumbersome or self-limiting due to size, appearance or difficulty of use.
Innovega digital eyewear with large fields of view would enable sufferers of macular degeneration a better means of meeting the visual demands of their environment and reading at normal distances. Electronic image amplification along with video feed of distance and near targets will facilitate the ability to enjoy their visual content regardless of the ambient illumination.
Innovega is committed to developing large field of view digital eyewear that can be used to help the millions of sufferers of this disease.